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Simple Summary: The accumulation of point mutations and/or recombination between 21 
different serotypes drives the evolution of the duck hepatitis A viruses (DHAVs). Duck 22 
viral hepatitis, caused by DHAV, is a highly infectious disease that has been detected in 23 
Egypt since 1970. Low performance, nervous signs and sudden deaths of young ducklings 24 
were the main characteristics of the disease. Identification of the causative agent through 25 
viral and molecular detection of the causative virus was the aim of this study. The causa- 26 
tive virus was isolated in embryonated duck eggs (EDEs), with complete genome se- 27 
quencing that indicated the viral clustering with Chinese duck hepatitis virus 1 that may 28 
help in new vaccine manufacturing and development of a more sensitive diagnostic assay. 29 
Future studies to evaluate potential protection of an available market vaccine against the 30 
newly detected isolates will be needed. 31 
Abstract: Duck hepatitis virus, DHV) is one of the commercially important diseases of ducklings, 32 
worldwide. It is an acute and highly infectious disease of ducklings caused by three different sero- 33 
types (1-3) of duck hepatitis A virus (DHAV) and serotype 1 is the most common in poultry. To 34 
date, little is known about the prevalence and genetic characterisation of DHAV-1 in Egypt. In the 35 
current study, isolation and complete genomic analyses of DHAVs circulating in commercial duck 36 
farms in different Egyptian governorates were conducted. A total of eighteen samples were col- 37 
lected from six Egyptian governorates of 3-11 days old ducklings (Pekin and Mullard) with a history 38 
of nervous signs and high mortality rates. Five out of eighteen, 5/18) samples were screened positive 39 
for the DHAV-1 based on the VP1 gene. These samples were individually used for virus isolation 40 
in embryonated duck embryo, EDE) followed by complete genome sequencing. Phylogenomic anal- 41 
yses showed that DHAV serotype I; genotype I was diversified into four different groups ( 1, 2, 3 42 
and 4). Most of the recent circulating Egyptian DHAV strains are clustered within group 4 while 43 
isolates characterized within this study were clustered within group 1. Recombination analyses re- 44 
vealed that the emergence of a new recombinant virus; DHAV-1 strain Egypt-10/2019 through re- 45 
combination. Likewise, the selective pressure analyses showed the existence, inside or near areas of 46 
the viral attachment or related functions, of positive scores highlighting the importance of natural 47 
selection and viral evolution mechanism at different protein domains. The findings of this study 48 
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provide an updated information on the epidemiological and genetic features of DHAV-1 strains and 49 
underscore the importance of DHAV surveillance as well as re-evaluation for the currently used 50 
vaccines.  51 
Keywords: Duck hepatitis virus; Ducklings; Genotype I; Natural selection; Vaccines 52 
 53 
1. Introduction 54 
Duck viral hepatitis (DVH) is a highly contagious disease of ducks characterized by 55 
severe morbidity and mortality particularly in ducklings under the age of four weeks old 56 
[1]. Duck hepatitis A virus (DHAV), causative of DVH, is classified into three types I, II 57 
and III. The DHAV type I belongs to the genus Avihepatovirus, family Picornaviridae and 58 
has three distinguishable serotypes designated as serotype 1, 2 and 3. Meanwhile, DHAV 59 
types II and III were recently classified as duck astrovirus 1 and 2 (DAstV-I and DAstV- 60 
II) and belong to the family Astroviridae and are antigenically distinct from DHAV type I. 61 
DHAV serotype 1 is the most widespread serotype, however, serotype 2 was reported in 62 
Taiwan and serotype 3 was first characterized in South Korea and China [2, 3]. The evo- 63 
lution of the DHAV is driven by accumulation of point mutations and/or recombination 64 
between different serotypes [4].  65 
DHAV has a single-strand positive-sense RNA genome of ~7.8 kb size that encodes 66 
a single viral polyprotein (VP) flanked with untranslated regions (UTR) at the 5’ and 3’ 67 
ends [6]. The 5’ UTR has distinctive internal ribosome entry site (IRES), which is essential 68 
for initiating translation and virus RNA synthesis. The VP polyprotein is ~2200 amino 69 
acids in length and is spliced into three structural proteins (VP0, VP1 and VP3) and nine 70 
non-structural proteins (2A1, 2A2, 2A3, 2B, 2C, 3A, 3B, 3C and 3D/RNA-dependent RNA- 71 
polymerase). VP0 is further subdivided into VP2 and VP4. The VP1 protein is the highly 72 
variable [6- 8] and plays a major role in receptor binding, virulence and immunogenicity 73 
[9].  74 
DHAV was reported in Egypt in the late 1970s [10], and later, several reports of the 75 
disease outbreaks have been documented from Egypt [11- 13]. These reports mainly fo- 76 
cused on partial sequencing of the 5’UTR, VP1 and 3D genes and thus fail to provide a 77 
comprehensive genome wide evolutionary insights. Since the expansion of the Egyptian 78 
commercial duck farms, DHAV has caused devastating losses and pose a major threat to 79 
the commercial duck farms [11- 13]. To effectively control disease, mass vaccination pro- 80 
grammes have been implemented in Egypt through vaccination of breeder ducks using 81 
attenuated vaccines produced from E52 Rispens strain [11, 14, 15]. Therefore, it is of par- 82 
amount importance to establish epidemiological insights into the virus evolution to iden- 83 
tify risks and challenges. The aim of current study is to investigate the prevalence of 84 
DHAV in ducklings with a history of high mortality in different Egyptian governorates 85 
between 2018-2020 based on virus isolation and complete genome sequencing from dif- 86 
ferent Egyptian provinces. 87 
2. Materials and Methods 88 
2.1. Ethics statement 89 
Samples were collected by trained veterinarians from duck flocks kept as commercial 90 
livestock in farms in Egypt. Tissue samples (liver and spleen) were obtained from dead 91 
ducklings, which did not require any anesthesia. Samples processing and virus isolation 92 
procedures were carried out under strict accordance with the guidance and regulations of 93 
animal welfare and health that approved by the Ethics Committee at Veterinary Serum 94 
and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Abbassia, 95 
Cairo, Egypt. 96 
Animals 2021, 11, x FOR PEER REVIEW 3 of 16 
 
 
2.2. Samples collection, Virus detection and Isolation 97 
Eighteen samples (liver and spleen) were collected between 2018 and 2020 from dif- 98 
ferent commercial duck flocks (Pekin and Mullard) of 3 to 11-day old that had a history 99 
of nervous signs and high mortalities within six Egyptian governorates (Table 1). Liver 100 
and spleen samples from each farm/flock were pooled and treated as one sample/farm. 101 
All samples were stored at -80 °C until processing. Viral RNA was extracted from the 102 
supernatant of tissue homogenates using the QIAamp Viral RNA Mini kit (Qiagen, 103 
GmbH, Germany) according to the manufacturer’s instructions. RT-PCR assay was con- 104 
ducted to detect DHAV through partial amplification of VP1 gene [9]. Virus isolation was 105 
carried out for the RT-PCR-positive samples by inoculation into the allantoic cavity of 10 106 
to 14-day-old embryonated duck embryos (EDEs) according to the standard protocols [16] 107 
for three consecutive passaging. Eggs were candled daily for up to 7 days and embryos 108 
were examined for pathologic lesions including stunting, oedema and/or haemorrhages 109 
particularly in the liver, kidneys and spleen [16]. 110 
Table 1. Data of collected samples for duck hepatitis A virus screening from 2018 to 2020 in Egypt. 111 
Sample ID Breed Age (days) Governorate Year Virus detection 
(RT-PCR) 
Strain 
1 Pekin 5 Giza 
 
2018 Yes  DHAV-1 strain Egypt-
1/2018 
2 Pekin 4 Monufia 2018 -  - 
3 Mallard 6 Qalyubia 2018 -  - 
4 Mallard 5 Monufia 
 
2020 Yes  DHAV-1 strain Egypt-
4/2020 
5 Pekin 7 Qalyubia 
 
2019 -  - 
6 Mallard 6 Giza 2019 -  - 
7 Mallard 9 Faiyum 2018 -  - 
8 Pekin 8 Giza 2019 -  - 
9 Mallard 10 Gharbia 2019 -  - 
10 Pekin 4 Giza 
 
2019 Yes  DHAV-1 strain Egypt-
10/2019 
11 Pekin 3 Giza 2020 -  - 
12 Mallard 10 Monufia 2019 -  - 
13 Pekin 4 Beni Suef 
 
2020 Yes  DHAV-1 strain Egypt-
13/2020 
14 Pekin 4 Faiyum 
 
2019 Yes  DHAV-1 strain Egypt-
14/2019 
15 Mallard 9 Beni Suef 2019 -  - 
16 Mallard 3 Giza 2020 -  - 
17 Pekin 8 Qalyubia 2019 -  - 
18 Mallard 5 Faiyum 2020 -  - 
-: means negative. 112 
 113 
 114 
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2.3. Complete genome sequencing 115 
Total RNA was extracted from the allantoic fluid using Trizol reagent (Life Technol- 116 
ogies, USA) according to the manufacturer’s instructions. The concentration and purity of 117 
extracted RNA were measured using a spectrophotometer, ND-1000 (Nanodrop Technol- 118 
ogies, USA), and the integrity of RNA was visualized by electrophoresis in a 1.2% formal- 119 
dehyde agarose gel stained with GelRed®, Biotium, USA. The extracted RNA kept at −80°C 120 
until use. Complete genome sequencing was carried out as previously described [17]. In 121 
order to amplify nine overlapped PCR fragments, nine pairs of specific primers were used. 122 
A gel purification kit (Invitrogen, CA, USA) was used to the purify PCR products. These 123 
products were then TA-cloned into the pMD18-T vector (Takazawa, Japan) according to 124 
the manufacturer's protocol. The TA-cloned products were transformed into E. coli strain 125 
DH5α cells (Invitrogen, UK). The positive clones were selected by PCR and sequenced 126 
with the dideoxy terminal termination method using Applied Biosystems genetic analyser 127 
3500xl (ThermoFisher, MA, USA) by Source Bioscience Co., Ltd., UK. 128 
2.4. Genetic and phylogenetic analyses 129 
The obtained nucleotide sequences were aligned using MUSCLE v. 3.8.31 [19], ana- 130 
lysed with the DNAstar (DNASTAR Inc.) programs and submitted to GenBank database 131 
under the following accession numbers MZ004919-MZ004923. The nucleotide pairwise 132 
identity scores were predicted using the Sequence Demarcation Tool, SDT) through a 133 
color-coded matrix [19]. Phylogenetic analyses were conducted using MEGA, Molecular 134 
Evolutionary Genetics Analysis) version 6.0 [20] (Tamura et al., 2013. The phylogenetic 135 
trees were constructed using the Maximum Likelihood, ML) method using RaxML ver- 136 
sion 8.2.11 [21] and general time-reversible (GTR) model of nucleotide substitution with 137 
gamma-distributed rate variation among sites was selected based on the jModelTest [22].  138 
2.5. Detection of putative recombination and Selective pressure 139 
The Recombination Detection Program 4 (RDP v.4.97) software has been used to de- 140 
tect potential recombination events in the DHAV complete genomes [23] through various 141 
program detection methods: RDP (Genecov, Bootscan, Maxchi, Chimaera, Siscan and 142 
3Seq) with a modified P-value of 0.05. Only recombination with no less than five inde- 143 
pendent methods were considered optimistic. The Synonymous-Non-Synonymous Anal- 144 
ysis Program (SNAP) was used to predict the VP1 gene-specific estimates of dN/dS [24]. 145 
The number of potential synonymous and non-synonymous changes were counted as 146 
well as the number of actual synonymous and non-synonymous changes in codon be- 147 
tween each pair. The dN/dS ratio was calculated by comparing the proportion of observed 148 
non-synonymous substitutions over the proportion of observed synonymous substitu- 149 
tions. These were then adjusted for multiple hits using the Jukes–Cantor correction [24]. 150 
2.6. Histopathology 151 
Liver samples were collected, fixed in neutral buffered formalin 10%, washed, dehy- 152 
drated, cleared, and embedded in paraffin [25]. The paraffin-embedded blocks were sec- 153 
tioned at 5µm thickness and stained with Haematoxylin and Eosin for light microscopic 154 
examination, Olympus BX50, Tokyo, Japan. Semiquantitative histopathologic scoring was 155 
carried out according to a modified scoring system [13] for microscopic evaluation of he- 156 
patic tissue damage  on a scale from 0 to 3 based on the lesion severity grade (mild, mod- 157 
erate, severe) as follow:  0 = no changes, 1 = mild, 2 = moderate, 3 = severe. Briefly the 158 
assigned alterations (five parameters) were congestion, hemorrhage, vacuolar degenera- 159 
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3. Results 164 
3.1. Virus screening and isolation 165 
All samples were collected from ducklings showing lethargic, nervous signs of 166 
ataxia, and high mortality rate (60%). Upon necropsy, livers and spleens were enlarged 167 
and haemorrhagic, petechial or ecchymotic. RT-PCR was carried out for screening of 168 
DHAV-1 based on VP1 gene. Five samples were positive out of eighteen (5/18; 27.8%) 169 
(Table 1). Pekin duckling breed showed higher infection rate (4/5; 80%) compared to Mal- 170 
lard breed (1/5; 20%) (Table 1). The RT-PCR positive samples (n=5) were subjected to virus 171 
isolation on EDEs for three passages and observed embryonic deaths within 5–7 days post 172 
inoculation. Embryonic examination showed oedema with abdominal distension, cutane- 173 
ous haemorrhages, stunting or dwarfing, hepatitis and enlarged congested kidneys and 174 
spleens on the second passage. The harvested allantoic fluid was negative HA to exclude 175 
the chance of any mixed infection with hemagglutinating viruses (Newcastle disease virus 176 
or avian influenza viruses; H5N1, H5N8 and H9N2 or duck adenovirus 1) which are en- 177 
demic in Egypt. 178 
3.2. Genetic Characterization of complete genomes 179 
Genetic recombination and point mutations are the main driving forces of DHAV 180 
evolution (Wei, et al., 2012. Unfortunately, due to unavailability of any complete genome 181 
sequences for Egyptian DHAV-1 viruses on databases, it was difficult to compare the 182 
whole genome. The studies DHAV-1 isolates complete genomic length is around 7,691 183 
nucleotides (nt), with the exclusion of a 17-nt poly (A) 3’ end tail. Single open reading 184 
frame (ORF) has a size of 6,750 nt, encodes a putative polyprotein precursor of 2,249 amino 185 
acids, flanked by a 627-nt (UTR) region, and a 315-nt 3’ UTR. The process of cleavage was 186 
observed in a total of 11 cleavage sites, which lead to the generation of 12 proteins, VP0, 187 
VP3, VP1, 2A1, 2A2, 2A3, 2B, 2C, 3A, 3B, 3C, and 3D. 188 
Interestingly, the nucleotide identity matrix for the VP1 gene of our reported isolates 189 
ranged from 92% to 95% compared to the previously reported Egyptian field strains while 190 
96% to 98% identity with the vaccine strain (Figure 1A) suggesting that these strains might 191 
be driven from the DHAV-1 vaccine and or due to the role of vaccination pressure over 192 
the field strains. On the other hand, there are three hypervariable regions (HVRs) at the 193 
VP1 protein C-terminal amongst DHAV-1 strains showed a high level of genetic diversity 194 
[7]. In this study, two hypervariable areas (aa 180–193 and aa 205–219) revealed marked 195 
amino acids substitutions compared to the previously reported DHAV-1 field and vaccine 196 
strains. The reported isolates possessed S182P (DHAV-1 strain Egypt-4/2020), G/E184K 197 
(DHAV-1 strain Egypt-14/2019, DHAV-1 strain Egypt-1/2018, DHAV-1 strain Egypt- 198 
13/2020 and DHAV-1 strain Egypt-4/2020), N186K (DHAV-1 strain Egypt-14/2019 and 199 
DHAV-1 strain Egypt-10/2019) and V187D mutations in the carboxy terminal region (Fig- 200 
ure 1B). Other mutations observed in the VP1 protein as shown in Fig S1. 201 





Figure 1. The pairwise identities plot of VP1 gene for DHAV-1 isolates reported in this study (red colored) aligned by ClustalW 204 
and displayed by a) Sequence Demarcation Tool, SDT) software and b) localization of specific mutations in the hyper variable areas 205 
(aa 180–193 and aa 205–219) within the VP1 protein of the newly identified DHAV-1 strains. 206 
 207 
 208 




Figure 2. Phylogenetic analyses based on 3D gene of the newly identified DHAV-1 strains (highlighted with red color along with red 210 
arrows) in Egypt between 2018-2020 showed the clustering pattern for the studied DHAV-1 strains. DHAV-1, genotype I is divided 211 
into four groups (1, 2, 3, and 4) that are highlighted by colour boxes as follow; group 1 (light blue), group 2 (light green), group 3 212 
(light pink) and group 4 (light yellow). The phylogenetic trees were constructed using the Maximum Likelihood (ML) method using 213 
RaxML version 8.2.11 and general time-reversible (GTR) model of nucleotide substitution with gamma-distributed rate variation 214 
among sites was selected based on the jModelTest. Bootstrap values (>60%) are indicated above the branches of the tree. 215 
3.3. Phylogenetic analyses 216 
Previous studies have classified the DHAV-1 isolates into four major 217 
genogroups/genotypes, GI, GII, GIII and GIV) based on the phylogenetic analysis of the 218 
VP1 gene (Gao et al., 2012). In the current study, we selected representative strains for GI 219 
to be included within all the phylogenetic analyses especially due to the high similarity 220 
between the previous reported Egyptian DHAV-1 strains with the Chinese strains of GI 221 
(Mansour et al., 2019). Phylogenetic analysis revealed that most of the Egyptian DHAV-1 222 
isolates are clustered within group 4 of DHAV-1 genotype I while our five isolates re- 223 
ported in this study were clustered within group 1 based on 3D gene (Figure 2), 5’UTR 224 
(Figure 3), VP1 gene (Figure 4) and complete genome (Figure 5). Interestingly, most of the 225 
previously characterized Egyptian DHAV-1 strains were clustered within group 4 where 226 
all characteried isolates were clustered in group 1 that were subdivided into at least three 227 
subgroups. Due to unavaulabilty for the Egyptian complete genome sequences, we tried 228 
to compare between the phylogenetic trees based on either the 3D (Fig S2), 5’UTR (Fig S3) 229 
or VP1 (Fig S4) genes compared to the complete genome based phylogeny to have the 230 
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closest model to construct the evolutionary trees based on which gene and to compute a 231 
consensus tree in the context of a bootstrap analysis. 232 
 233 
Figure 3. Phylogenetic analyses based on 5’UTR gene of the newly identified DHAV-1 strains (highlighted with red color along with 234 
red arrows) in Egypt between 2018-2020 showed the clustering pattern for the studied DHAV-1 strains. DHAV-1, genotype I is 235 
divided into four groups (1, 2, 3, and 4) that are highlighted by colour boxes as follow; group 1 (light blue), group 2 (light green), 236 
group 3 (light pink) and group 4 (light yellow). The phylogenetic trees were constructed using the Maximum Likelihood (ML) 237 
method using RaxML version 8.2.11 and general time-reversible (GTR) model of nucleotide substitution with gamma-distributed 238 










Figure 4. Phylogenetic analyses based on VP1 gene of the newly identified DHAV-1 strains (highlighted with red color along with 246 
red arrows) in Egypt between 2018-2020 showed the clustering pattern for the studied DHAV-1 strains. DHAV-1, genotype I is 247 
divided into four groups (1, 2, 3, and 4) that are highlighted by colour boxes as follow; group 1 (light blue), group 2 (light green), 248 
group 3 (light pink) and group 4 (light yellow). The phylogenetic trees were constructed using the Maximum Likelihood (ML) 249 
method using RaxML version 8.2.11 and general time-reversible (GTR) model of nucleotide substitution with gamma-distributed 250 








Figure 5. Phylogenetic analyses based on complete genome of the newly identified DHAV-1 strains (highlighted with red color along 256 
with red arrows) in Egypt between 2018-2020 showed the clustering pattern for the studied DHAV-1 strains. DHAV-1, genotype I is 257 
divided into four groups (1, 2, 3, and 4) that are highlighted by colour boxes as follow; group 1 (light blue), group 2 (light green), 258 
group 3 (light pink) and group 4 (light yellow). The phylogenetic trees were constructed using the Maximum Likelihood (ML) 259 
method using RaxML version 8.2.11 and general time-reversible (GTR) model of nucleotide substitution with gamma-distributed 260 
rate variation among sites was selected based on the jModelTest. Bootstrap values (>60%) are indicated above the branches of the 261 
tree. 262 
3.4. Recombination and selective pressure analyses 263 
Recombination is an important approach to achieve genetic diversity and is recog- 264 
nized as an important part in the evolution of viruses. Recombinant strains could have 265 
distinct biological characteristics and yield different clinical forms compared to parental 266 
strains. However, the molecular understanding of recombination of DHAV-1 are little 267 
known. Therefore, the analysis of the recombination events in DHAV-1 could provide 268 
valuable information for the understanding of DHAV-1 evolution. Our findings showed 269 
that emergence of one new recombinant virus, which are detected in the current study 270 
with high score p < 0.01 and recombinant score >0.6. The recombinant DHAV-1 strain 271 
Egypt-10/2019 could be emerged as a result of recombination between two strains; 272 
EF427899.1 DHAV-1 isolate CL (major parent) - KP721458 DHAV-1 isolate Du/CH/JS2013 273 
(minor parent), both are of Chinese origin (Asian lineage) that is closely related to the 274 
Egyptian strains (Figure 6A). In addition, the recombination events have been confirmed 275 
with the phylogeny based on the region included within recombination within major and 276 
minor parents (Figure S5). The uniform differences in dN-dS were estimated for each po- 277 
sition to further determine the existence of a differential selective pressure intensity on 278 
the VP1 gene. Scores above 0 indicate a greater diversification of selection while this value 279 
was also used for the measurement of a cumulative score by summing codon per codon. 280 
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In addition, the diversification trend in VP1 protein regions was emphasized in this score. 281 
The accumulated difference of nonsynonymous replacement (dN) to synonymous substi- 282 
tution (dS), i.e. (dN-dS) of the Egyptian DHAV-1 has been shown to be under high posi- 283 
tive selection along with the VP1 protein (Figure 3B). 284 
A pairwise comparison bioinformatics approach (SNAP) was applied to determine 285 
the synonymous and non-synonymous substitution rates and selective evolutionary pres- 286 
sure for the VP1 protein. The selection profiles of the amino acid sequence for all the five 287 
Egyptian DHAV-1 strains showed different patterns within the VP1 protein numbers 288 
above zero indicate the positive selection, around zero shows the neutral selection, and 289 
below zero indicates the negative or purifying selection (Figure 6B).  290 
 291 
Figure 6. Recombination and selective pressure analyses. A) Recombination detection analysis displaying possible recombination 292 
events predicted within the VP1 gene of the Egyptian DHAV-1 strains. B) Cumulative dN/dS of the average synonymous and non- 293 
synonymous substitutions moving codon by codon across VP1 gene. 294 
3.5. Histological examinations 295 
Light microscopic examination for the liver of non infected (negative control) duck- 296 
lings compared to DHAV infected ducklings revealed remarkable histopathological alter- 297 
ations exhibited by severe dilatation and congestion of central veins and hepatic sinus- 298 
oids, marked vacuolar degeneration of hepatocytes, hepatocellular necrosis associated 299 
with marked hepatocellular apoptosis. The portal triad showed hyperplasia of biliary ep- 300 
ithelium, portal infiltration with mononuclear cells, mainly lymphocytes and heterophils. 301 
Additionally, perivascular inflammatory cells infiltration (lymphocytes and heterophils) 302 
and focal hepatic hemorrhage were also seen in the examined sections. (Figure 7). The 303 
recombinant strain (DHAV-1 strain Egypt-10/2019) showed significant histopathological 304 
alterations compared to normal (negative control) and other DHAV-1 strains identified in 305 
this study (Table S1). 306 




Figure 4. Photomicrographs of Haematoxylin and Eosin-stained liver sections of negative control (non infected) compared to DHAV- 308 
1 infected ducklings showing severe dilatation and congestion of central vein (white arrow), vacuolar degeneration of hepatocytes 309 
(black arrow), marked hepatocellular apoptosis (red arrow), inflammatory cells infiltration, mononuclear and heterophils (blue ar- 310 
row), haemorrhage (yellow arrow) and hyperplasia of biliary epithelium (green arrow). Non-infected (negative control) ducklings 311 
showed normal liver. Scale bar show 50 µm. 312 
4. Discussion 313 
Despite DHAV causes devastating losses in duck industry since decades within the 314 
African and Middle East countries including Egypt, there is little information available on 315 
the disease prevalence. The high mortality rate associated with the DHAV-1 outbreaks, 316 
which is often over 50% and can exceed 95% in field conditions, continues to be a threat 317 
to duck farms [12, 26]. The infection severity of young ducklings with DHAV is mainly 318 
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age-dependent due to their immune system immaturity, which is unable to protect them 319 
from virus infection and replication [27].  Previous studies have reported that Muscovy 320 
ducklings were stable carriers for DHAV-1 infections while Pekin, Mallard and hybrid 321 
breeds infections are associated with acute disease.  Furthermore, Muscovy ducks are ge- 322 
netically distinct and form a distinctive genetic group away from other duck breeds [28]. 323 
However, this genetic variation remains unclear for the susceptibility to DHAV-1 infec- 324 
tion. Of note, pancreatitis and encephalitis have been associated with recent variant 325 
strains belonging to DHAV genotype 3 and revealed 25 – 40% deaths without serious liver 326 
lesions [29, 30].  327 
In this study, DHAV was screened in suspected duck farms in six of Egypt's prov- 328 
inces. The majority of the examined field outbreaks were in ducklings aged 3-11 days old. 329 
Collected samples homogenate were screened based on VP1 gene amplification and RT- 330 
PCR testing revealed five positive sample. These positive samples were isolated in 10-14- 331 
day EDEs. Pathogens others than DHAV such as Pasteurella, Salmonella or E. coli could 332 
be responsible for high mortality rate in ducklings particularly in DHAV-negative sam- 333 
ples. In this study, we tried to allocate majority of available DHAV-1 strains on databases 334 
to have genotyping based classification system based on complete genome, VP1, 3D and 335 
5’UTR. Deep genetic analysis showed that C-terminal of the VP1 protein of DHAV-1 car- 336 
ried two hypervariable regions (HVRs); HVR1 (180–194) and HVR2 (205–219) that have 337 
been correlated with DHAV-1 virulence differences [9, 31]. Besides that, Wang et al. [6] 338 
have showed that Asian virulent and attenuated DHAV-1 strains have similar VP1 se- 339 
quences with minor differences in the VP0 and VP3. This suggests that DHAV-1 virulence 340 
may be correlated with other genomic regions other than VP1 protein. Most of previous 341 
studies have classified the DHAV based on the antigenic and/or neutralization character- 342 
istics that classified DHAV-1 strains into four main groups (1, 2, 3 and 4) [13, 26]. The 343 
Egyptian isolates were clustered along with Chinese virulent viruses’ group 4 that has 344 
been subgrouped into A, B1, B2, and C subgroups according to their geographic distribu- 345 
tion [13, 26]. Putative amino acids revealed distinctively marked amino acids substitutions 346 
within two-hypervariable regions (aa 180–193 and aa 205–219) compared to the vaccine 347 
strains being used in the Egyptian industry. Our isolates carried S182P (DHAV-1 strain 348 
Egypt-4/2020), G/E184K (DHAV-1 strain Egypt-14/2019, DHAV-1 strain Egypt-1/2018, 349 
DHAV-1 strain Egypt-13/2020 and DHAV-1 strain Egypt-4/2020), N186K (DHAV-1 strain 350 
Egypt-14/2019 and DHAV-1 strain Egypt-10/2019) and V187D mutations in the carboxy 351 
terminal region. 352 
Phylogenetic analyses revealed that DHAVs genotype I was diversified into four ma- 353 
jor groups; 1, 2, 3 and 4 where our isolates were clustered within group 1. In addition, 354 
sequencing and phylogenetic analyses indicated that the Egyptian field strains are distin- 355 
guishable from the commercial used vaccine strain where lower identity was observed in 356 
VP1. The VP1 is the most external surface protein and is involved in receptor binding and 357 
contained neutralizing epitopes [9]. Likewise, it is highly recommended to update the 358 
vaccines according to the circulating viruses being reported from outbreaks in ducklings 359 
[3, 32]. Interestingly, the DHAV-1 strain Egypt-10/2019 (recombinant strain) exhibited sig- 360 
nificant histopathological alterations compared to normal (negative control) and other 361 
DHAV-1 strains identified in this study while no significant differences were identified in 362 
the mortality rates of affected duckling flocks.  363 
In conclusion, it is unclear whether the commercially available vaccine is not able to 364 
protect ducklings from the field strains due to antigenic and or genetic differences. There- 365 
fore, vaccine effectiveness studies are needed to investigate the protective efficacy of such 366 
vaccines against newly emerged strains. Matching studies between the antigenic and ge- 367 
netic relationship between these strains are also required. In addition, further research is 368 
needed to catalogue various DHAV strains based on the proposed virulence markers. 369 
Meanwhile, in vivo testing of the commercial DHAV vaccines currently used are im- 370 
portant to demonstrate their efficacy in battling DHAV strains and to investigate the 371 
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pathobiology of newly evolving DHAV-1 strains, which can aid exploring their pathogen- 372 
esis and monitoring their developmental changes. Likewise, the genetic variations be- 373 
tween recent Egyptian strains and commercial vaccines is urging the efficacy assessment 374 
and/or production of new vaccine candidates. Finally, studying the relationship between 375 
DHAV-1 infection susceptibility and biodiversity of duck breeds will lead to better un- 376 
derstanding the pathogenic heterogeneity of various DHAV-1. 377 
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